Koers Compass Biotechnologies, Inc. Other OTC
Aandelen
US20452Q1031
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 158K 147K |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 | Nettowinst (verlies) 2019 | - 0 | EV/omzet 2018 | - |
Nettoschuld 2018 | 516K 482K | Nettoschuld 2019 | 480K 449K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-2,59
x | K/w-verhouding 2019 |
-3,95
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Mathew Knowles
SAM | Sales & Marketing | - | 22-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,48% | 5,8 mld. | |
-26,22% | 3,92 mld. | |
+4,73% | 3,28 mld. | |
-20,86% | 2,77 mld. | |
-11,88% | 2,26 mld. | |
+46,64% | 1,95 mld. | |
-16,71% | 1,52 mld. | |
+44,65% | 1,49 mld. | |
-9,60% | 1,49 mld. |